Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations

By Uno Tsukasa   Niioka Takenori   Hayakari Makoto   Yasui-Furukori Norio   Sugawara Kazunobu   Tateishi Tomonori  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 2, 2007-02 ,pp. : 143-149

Springer Publishing Company

Access to resources Recommend Favorite

Omeprazole reduces antiplatelet action of clopidogrel

By  

Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Coadministration of omeprazole reduces atazanavir exposure levels

By  

Reactions Weekly, Vol. 1, Iss. 1034, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Bioavailability and Bioequivalence of Two Enteric-Coated Formulations of Omeprazole in Fasting and Fed Conditions

By Vaz-da-Silva Manuel   Loureiro Ana I.   Nunes Teresa   Maia Joana   Tavares Susana   Falcão Amilcar   Silveira Pedro   Almeida Luis   Soares-da-Silva Patricio  

Clinical Drug Investigation, Vol. 25, Iss. 6, 2005-01 ,pp. : 391-399

Adis International

Access to resources Recommend Favorite

Ascorbic acid [vitamin C], but not magnesium, reduces inhaled corticosteroid requirements in patients with asthma

By  

Inpharma, Vol. 1, Iss. 1528, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite